{"id":"39b5888be4e8","type":"article","url":"https://hartvaat.nl/2026/02/01/detectie-van-transthyretine-cardiale-amyloidose-met-kunstmatige-intelligentie/","title":"Detectie van transthyretine cardiale amyloïdose met kunstmatige intelligentie","title_en":"Detecting Transthyretin Cardiac Amyloidosis With Artificial Intelligence","category":"algemeen","category_label":"Algemeen","professions":["cardioloog","internist"],"tags":["cardiale-amyloidose"],"journal":"JAMA Cardiology","doi":"https://jamanetwork.com/journals/jamacardiology/fullarticle/2841169","source_url":"https://doi.org/https://jamanetwork.com/journals/jamacardiology/fullarticle/2841169","authors":[],"significance":7,"published":"2026-02-01","source_date":"2026-02-01","image":"","kennis":[],"congress":"","summary_en":"This study developed and evaluated an AI-augmented screening program for detecting transthyretin cardiac amyloidosis, demonstrating that machine learning applied to routine clinical data can identify patients with this increasingly recognized but underdiagnosed condition.","created":"2026-07-03T10:25:28Z","updated":"2026-07-03T13:24:53Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Niet-gerandomiseerde studie over de ontwikkeling en evaluatie van een AI-ondersteund screeningsprogramma voor de detectie van transthyretine cardiale amyloïdose.","abstract_original":"This nonrandomized clinical trial reports the development and evaluation of an artificial intelligence–augmented screening program designed to detect transthyretin cardiac amyloidosis."}